ZA87730B - 2-amino-3-formyl furane compounds - Google Patents

2-amino-3-formyl furane compounds

Info

Publication number
ZA87730B
ZA87730B ZA87730A ZA87730A ZA87730B ZA 87730 B ZA87730 B ZA 87730B ZA 87730 A ZA87730 A ZA 87730A ZA 87730 A ZA87730 A ZA 87730A ZA 87730 B ZA87730 B ZA 87730B
Authority
ZA
South Africa
Prior art keywords
formyl
amino
furane
compounds
furane compounds
Prior art date
Application number
ZA87730A
Other languages
English (en)
Inventor
Walter Loesel
Otto Roos
Gerd Schnorrenberg
Dietrich Arndts
Franz-Josef Kuhn
Erich Lehr
Richard Reichl
Guenter Schingnitz
Georg Speck
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA87730B publication Critical patent/ZA87730B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
ZA87730A 1986-02-03 1987-02-02 2-amino-3-formyl furane compounds ZA87730B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863603194 DE3603194A1 (de) 1986-02-03 1986-02-03 Neue 2-amino-3-formyl-furane, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen

Publications (1)

Publication Number Publication Date
ZA87730B true ZA87730B (en) 1988-10-26

Family

ID=6293224

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87730A ZA87730B (en) 1986-02-03 1987-02-02 2-amino-3-formyl furane compounds

Country Status (16)

Country Link
EP (1) EP0234329A1 (cs)
JP (1) JPS62185086A (cs)
KR (1) KR870007922A (cs)
AU (1) AU6823587A (cs)
CS (1) CS67287A2 (cs)
DD (1) DD260067A5 (cs)
DE (1) DE3603194A1 (cs)
DK (1) DK52687A (cs)
FI (1) FI870435A7 (cs)
HU (1) HU900157D0 (cs)
IL (1) IL81447A0 (cs)
NO (1) NO870408L (cs)
PL (1) PL263934A1 (cs)
PT (1) PT84240B (cs)
YU (1) YU13787A (cs)
ZA (1) ZA87730B (cs)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3143876A1 (de) * 1981-11-05 1983-05-11 Boehringer Ingelheim KG, 6507 Ingelheim Neue1-furyl-3,4-dihydroisochinoline diese enthaltende arzneimittel sowie verfahren zu deren herstellung und deren verwendung
DE3401018A1 (de) * 1984-01-13 1985-07-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung von 5,6-dihydro-pyrrolo(2,1-a)isochinolinen

Also Published As

Publication number Publication date
HU900157D0 (en) 1990-03-28
JPS62185086A (ja) 1987-08-13
AU6823587A (en) 1987-08-06
PT84240A (de) 1987-03-01
DK52687A (da) 1987-08-04
FI870435A7 (fi) 1987-08-04
NO870408D0 (no) 1987-02-02
PT84240B (pt) 1991-02-08
PL263934A1 (en) 1988-07-21
DD260067A5 (de) 1988-09-14
NO870408L (no) 1987-08-04
DK52687D0 (da) 1987-02-02
FI870435A0 (fi) 1987-02-02
EP0234329A1 (de) 1987-09-02
IL81447A0 (en) 1987-09-16
YU13787A (en) 1988-10-31
KR870007922A (ko) 1987-09-22
HUT47100A (en) 1989-01-30
DE3603194A1 (de) 1987-08-06
CS67287A2 (en) 1990-10-12

Similar Documents

Publication Publication Date Title
GB2188317B (en) 4-oxo-quinoline compounds
GB8601796D0 (en) Compounds
GB8726173D0 (en) Intermediate compounds
AR245099A1 (es) N-neoalcanamidas de alquilo inferior utiles como repelentes de insectos, composiciones domesticas, detergentes, repelentes y perfumes que las contienen.
GB8610909D0 (en) Compounds
GB8600651D0 (en) Compounds
GB8620951D0 (en) Compounds
ZA871061B (en) Cyanoethanimidamido compounds
GB8719062D0 (en) Compounds
GB8601371D0 (en) Compounds
EP0238443A3 (en) Dicyanobenzanthrone compounds
GB8719063D0 (en) Compounds
GB8600978D0 (en) Compounds
ZA87730B (en) 2-amino-3-formyl furane compounds
GB8630113D0 (en) Compounds
GB8604699D0 (en) Compounds
GB8620311D0 (en) Compounds
GB8615532D0 (en) Compounds
GB8620953D0 (en) Compounds
GB8621872D0 (en) Compounds
GB8622385D0 (en) Compounds
GB8626042D0 (en) Compounds
GB8626569D0 (en) Compounds
GB8614544D0 (en) Compounds
GB8630925D0 (en) Compounds